Skip to main content
SpringerLink
Log in

Polypharmacy

  • Chapter
  • First Online:
Medication-Related Falls in Older People

  • 1954 Accesses

Abstract

Polypharmacy is common among older adults, largely due to the need to treat the increasing number of diseases that present as a person ages. However, multiple medication use can lead to serious consequences such as adverse drug events and also contribute to geriatric syndromes. A number of strategies have been evaluated in an effort to improve polypharmacy. While such strategies consistently demonstrate significant reductions in inappropriate medication prescribing, their impact on clinical outcomes is equivocal. More research is needed to identify the most effective interventions to optimize medication use in the older population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ADE:

Adverse drug event

ADL:

Activity of daily living

CI:

Confidence interval

LUTS:

Lower urinary tract symptoms

MAI:

Medication appropriateness index

MNA:

Mini-nutritional assessment

NSAID:

Nonsteroidal anti-inflammatory drug

OR:

Odds ratio

OTC:

Over the counter

PIM:

Potentially inappropriate medication

RR:

Relative risk

SIADH:

Syndrome of inappropriate ADH secretion

SSRI:

Selective serotonin reuptake inhibitor

STOPP:

Screening tool of older person’s prescriptions

US:

United States

References

  1. United Nations Department of Economic and Social Affairs (2013) Population division. World population ageing. United Nations, New York

    Google Scholar 

  2. Federal Interagency Forum on Aging-related Statistics. Older Americans (2012) Key indicators of well-being. US Government Printing Office, Washington, DC

    Google Scholar 

  3. Statistics Canada. Population by sex and age group (2015). Available at: http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/demo10a-eng.htm. Accessed 4 Jan 2016

  4. European Commission (2015) The 2015 Ageing Report. Economic and budgetary projections of the 28 EU Member States (2013–2060);ISSN 1725–3217 Available at: http://europa.eu/epc/pdf/ageing_report_2015_en.pdf. Last accessed: April 15, 2016.

  5. Canadian Institute for Health Information (2011) Analysis in brief – seniors and the health care System: what is the impact of multiple chronic conditions? Available at: https://secure.cihi.ca/free_products/air-chronic_disease_aib_en.pdf. Last accessed: April 15, 2016.

  6. Department of Health (UK) (2001) Medicines and older people: implementing medicines-related aspects of the NSF for older persons Available at: http://www.wales.nhs.uk/sites3/documents/439/nsf%20for%20older%20people%20-%20medicines%20and%20older%20people.pdf. Last accessed: April 15, 2016.

  7. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST (2008) Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 300(24):2867–2878

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Martial L, Mantel-Teewisse AK, Jansen PAF (2013) Background paper 7.3 priority medicines for elderly Available at: http://www.who.int/medicines/areas/priority_medicines/Ch7_3Elderly.pdf. Accessed: April 15, 2016.

  9. Canadian Institute for Health Information (2015) Drug use among seniors on public drug programs in Canada, 2012. Available at: https://secure.cihi.ca/free_products/Drug_Use_in_Seniors_on_Public_Drug_Programs_2012_EN_web.pdf. Accessed 8 Sept 2015

  10. WHO Centre for Health Development (2004) Aging and health technical report volume 5. A glossary of terms for community health care and services for older persons. Available at: http://www.who.int/kobe_centre/ageing/ahp_vol5_glossary.pdf. Accessed 23 Nov 2015

  11. Brager R, Sloand E (2005) The spectrum of polypharmacy. Nurse Pract 30(6):44–50

    Article  PubMed  Google Scholar 

  12. Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN (2008) Polypharmacy: misleading, but manageable. Clin Interv Aging 3(2):383–389

    PubMed  PubMed Central  Google Scholar 

  13. Hajjar ER, Cafiero AC, Hanlon JT (2007) Polypharmacy in elderly patients. Am J Geriatr Pharmacother 5(4):345–351

    Article  PubMed  Google Scholar 

  14. Frazier SC (2005) Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs 31(9):4–11

    Article  PubMed  Google Scholar 

  15. Hohl CM, Dankoff J, Colacone A, Afilalo M (2001) Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 38(6):666–671

    Article  CAS  PubMed  Google Scholar 

  16. Salvi F, Marchetti A, D’Angelo F, Boemi M, Lattanzio F, Cherubini A (2012) Adverse drug events as a cause of hospitalization in older adults. Drug Saf 35(Suppl 1):29–45

    Article  PubMed  Google Scholar 

  17. Canadian Institute for Health Information – Analysis in Brief (2013). Adverse drug reaction-related hospitalizations among seniors, 2006 to 2011. Available at: https://secure.cihi.ca/free_products/Hospitalizations%20for%20ADR-ENweb.pdf. Accessed 3 Sept 2015

  18. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287(3):337–344

    Article  PubMed  Google Scholar 

  19. Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I et al (2005) Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 293(11):1348–1358

    Article  CAS  PubMed  Google Scholar 

  20. Dwyer LL, Han B, Woodwell DA, Rechtsteiner EA (2010) Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. Am J Geriatr Pharmacother 8(1):63–72

    Article  PubMed  Google Scholar 

  21. Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P et al (2012) Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci 67(6):698–704

    Article  PubMed  Google Scholar 

  22. Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ (2006) Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 54(10):1516–1523

    Article  PubMed  Google Scholar 

  23. Hajjar ER, Hanlon JT, Sloane RJ, Lindblad CI, Pieper CF, Ruby CM et al (2005) Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc 53(9):1518–1523

    Article  PubMed  Google Scholar 

  24. Stuijt CC, Franssen EJ, Egberts AC, Hudson SA (2008) Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacist-led medication review. Drugs Aging 25(11):947–954

    Article  PubMed  Google Scholar 

  25. Brulhart MI, Wermeille JP (2011) Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm 33(3):549–557

    Article  PubMed  Google Scholar 

  26. Silva C, Ramalho C, Luz I, Monteiro J, Fresco P (2015) Drug-related problems in institutionalized, polymedicated elderly patients: opportunities for pharmacist intervention. Int J Clin Pharm 37(2):327–334

    Article  CAS  PubMed  Google Scholar 

  27. Maher RL, Hanlon J, Hajjar ER (2014) Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 13(1):57–65

    Article  PubMed  Google Scholar 

  28. Hanlon JT, Fillenbaum GG, Ruby CM, Gray S, Bohannon A (2001) Epidemiology of over-the-counter drug use in community dwelling elderly: United States perspective. Drugs Aging 18(2):123–131

    Article  CAS  PubMed  Google Scholar 

  29. Hovstadius B, Petersson G (2012) Factors leading to excessive polypharmacy. Clin Geriatr Med 28(2):159–172

    Article  PubMed  Google Scholar 

  30. Wehling M (2011) Guideline-driven polypharmacy in elderly, multimorbid patients is basically flawed: there are almost no guidelines for these patients. J Am Geriatr Soc 59(2):376–377

    Article  PubMed  Google Scholar 

  31. Garfinkel D, Ilhan B, Bahat G (2015) Routine deprescribing of chronic medications to combat polypharmacy. Ther Adv Drug Safety 6(6):212–233

    Article  CAS  Google Scholar 

  32. Anthierens S, Tansens A, Petrovic M, Christiaens T (2010) Qualitative insights into general practitioners views on polypharmacy. BMC Fam Pract 11:65–2296

    Article  PubMed  PubMed Central  Google Scholar 

  33. Cherubini A, Oristrell J, Pla X, Ruggiero C, Ferretti R, Diestre G et al (2011) The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med 171(6):550–556

    Article  PubMed  Google Scholar 

  34. Dodd KS, Saczynski JS, Zhao Y, Goldberg RJ, Gurwitz JH (2011) Exclusion of older adults and women from recent trials of acute coronary syndromes. J Am Geriatr Soc 59(3):506–511

    Article  PubMed  PubMed Central  Google Scholar 

  35. Konrat C, Boutron I, Trinquart L, Auleley GR, Ricordeau P, Ravaud P (2012) Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs. PLoS One 7(3):e33559

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Cruz-Jentoft AJ, Carpena-Ruiz M, Montero-Errasquin B, Sanchez-Castellano C, Sanchez-Garcia E (2013) Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus. J Am Geriatr Soc 61(5):734–738

    Article  PubMed  Google Scholar 

  37. Mutasingwa DR, Aaro LE (2001) Injury registration in a developing country. A study based on patients’ records from four hospitals in Dar es Salaam, Tanzania. Cent Afr J Med 47(8):203–209

    CAS  PubMed  Google Scholar 

  38. Cox L, Kloseck M, Crilly R, McWilliam C, Diachun L (2011) Underrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelines. Can Fam Physician 57(7):e263–e269

    PubMed  PubMed Central  Google Scholar 

  39. Holmes HM, Hayley DC, Alexander GC, Sachs GA (2006) Reconsidering medication appropriateness for patients late in life. Arch Intern Med 166(6):605–609

    Article  PubMed  Google Scholar 

  40. Lee SJ, Leipzig RM, Walter LC (2013) Incorporating lag time to benefit into prevention decisions for older adults. JAMA 310(24):2609–2610

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Hill-Taylor B, Sketris I, Hayden J, Byrne S, O’Sullivan D, Christie R (2013) Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther 38(5):360–372

    Article  CAS  PubMed  Google Scholar 

  42. Wallace J, Paauw DS (2015) Appropriate prescribing and important drug interactions in older adults. Med Clin N Am 99(2):295–310

    Article  PubMed  Google Scholar 

  43. By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 63(11):2227–2246

    Article  Google Scholar 

  44. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P (2015) STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44(2):213–218

    Article  PubMed  Google Scholar 

  45. Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM et al (1994) A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 47(8):891–896

    Article  CAS  PubMed  Google Scholar 

  46. Hanlon JT, Artz MB, Pieper CF, Lindblad CI, Sloane RJ, Ruby CM et al (2004) Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 38(1):9–14

    Article  PubMed  Google Scholar 

  47. Cannon KT, Choi MM, Zuniga MA (2006) Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother 4(2):134–143

    Article  PubMed  Google Scholar 

  48. Hudhra K, Garcia-Caballos M, Casado-Fernandez E, Jucja B, Shabani D, Bueno-Cavanillas A (2015) Polypharmacy and potentially inappropriate prescriptions identified by Beers and STOPP criteria in co-morbid older patients at hospital discharge. J Eval Clin Pract 22(2):189–93

    Google Scholar 

  49. Oliveira MG, Amorim WW, de Jesus SR, Heine JM, Coqueiro HL, Passos LC (2015) A comparison of the Beers and STOPP criteria for identifying the use of potentially inappropriate medications among elderly patients in primary care. J Eval Clin Pract 21(2):320–325

    Article  PubMed  Google Scholar 

  50. Walsh KA, O’Riordan D, Kearney PM, Timmons S, Byrne S (2016) Improving the appropriateness of prescribing in older patients: a systematic review and meta-analysis of pharmacists’ interventions in secondary care. Age Ageing 45(2):201–9

    Google Scholar 

  51. Gray SL, Lai KV, Larson EB (1999) Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf 21(2):101–122

    Article  CAS  PubMed  Google Scholar 

  52. Sera LC, McPherson ML (2012) Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy. Clin Geriatr Med 28(2):273–286

    Article  PubMed  Google Scholar 

  53. Petrovic M, van der Cammen T, Onder G (2012) Adverse drug reactions in older people: detection and prevention. Drugs Aging 29(6):453–462

    Article  PubMed  Google Scholar 

  54. Reason B, Terner M, Moses McKeag A, Tipper B, Webster G (2012) The impact of polypharmacy on the health of Canadian seniors. Fam Pract 29(4):427–432

    Article  PubMed  Google Scholar 

  55. Marcum ZA, Amuan ME, Hanlon JT, Aspinall SL, Handler SM, Ruby CM et al (2012) Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatr Soc 60(1):34–41

    Article  PubMed  Google Scholar 

  56. Nguyen JK, Fouts MM, Kotabe SE, Lo E (2006) Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 4(1):36–41

    Article  PubMed  Google Scholar 

  57. Goldberg RM, Mabee J, Chan L, Wong S (1996) Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 14(5):447–450

    Article  CAS  PubMed  Google Scholar 

  58. Inouye SK, Studenski S, Tinetti ME, Kuchel GA (2007) Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc 55(5):780–791

    Article  PubMed  PubMed Central  Google Scholar 

  59. Crentsil V, Ricks MO, Xue QL, Fried LP (2010) A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associated with medication use. Am J Geriatr Pharmacother 8(3):215–224

    Article  PubMed  Google Scholar 

  60. Jyrkka J, Enlund H, Lavikainen P, Sulkava R, Hartikainen S (2011) Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf 20(5):514–522

    Article  PubMed  Google Scholar 

  61. Rosso AL, Eaton CB, Wallace R, Gold R, Stefanick ML, Ockene JK et al (2013) Geriatric syndromes and incident disability in older women: results from the women’s health initiative observational study. J Am Geriatr Soc 61(3):371–379

    Article  PubMed  PubMed Central  Google Scholar 

  62. Lau DT, Mercaldo ND, Shega JW, Rademaker A, Weintraub S (2011) Functional decline associated with polypharmacy and potentially inappropriate medications in community-dwelling older adults with dementia. Am J Alzheimer's Dis Other Demen 26(8):606–615

    Article  Google Scholar 

  63. Pickering G (2004) Frail elderly, nutritional status and drugs. Arch Gerontol Geriatr 38(2):174–180

    Article  CAS  PubMed  Google Scholar 

  64. Zadak Z, Hyspler R, Ticha A, Vlcek J (2013) Polypharmacy and malnutrition. Curr Opin Clin Nutr Metab Care 16(1):50–55

    Article  CAS  PubMed  Google Scholar 

  65. Griep MI, Mets TF, Collys K, Ponjaert-Kristoffersen I, Massart DL (2000) Risk of malnutrition in retirement homes elderly persons measured by the “mini-nutritional assessment”. J Gerontol A Biol Sci Med Sci 55(2):M57–M63

    Article  CAS  PubMed  Google Scholar 

  66. Heuberger RA, Caudell K (2011) Polypharmacy and nutritional status in older adults: a cross-sectional study. Drugs Aging 28(4):315–323

    Article  PubMed  Google Scholar 

  67. Agostini JV, Han L, Tinetti ME (2004) The relationship between number of medications and weight loss or impaired balance in older adults. J Am Geriatr Soc 52(10):1719–1723

    Article  PubMed  Google Scholar 

  68. Sexton CC, Coyne KS, Thompson C, Bavendam T, Chen CI, Markland A (2011) Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study. J Am Geriatr Soc 59(8):1465–1470

    Article  PubMed  Google Scholar 

  69. Chiarelli PE, Mackenzie LA, Osmotherly PG (2009) Urinary incontinence is associated with an increase in falls: a systematic review. Aust J Physiother 55(2):89–95

    Article  PubMed  Google Scholar 

  70. Tsakiris P, Oelke M, Michel MC (2008) Drug-induced urinary incontinence. Drugs Aging 25(7):541–549

    Article  CAS  PubMed  Google Scholar 

  71. Hall SA, Chiu GR, Kaufman DW, Wittert GA, Link CL, McKinlay JB (2012) Commonly used antihypertensives and lower urinary tract symptoms: results from the Boston Area Community Health (BACH) Survey. BJU Int 109(11):1676–1684

    Article  PubMed  Google Scholar 

  72. Kashyap M, Tu le M, Tannenbaum C (2013) Prevalence of commonly prescribed medications potentially contributing to urinary symptoms in a cohort of older patients seeking care for incontinence. BMC Geriatr 13:57–2318

    Article  PubMed  PubMed Central  Google Scholar 

  73. Nuotio M, Jylha M, Luukkaala T, Tammela TL (2005) Health problems associated with lower urinary tract symptoms in older women. A population-based survey. Scand J Prim Health Care 23(4):209–214

    Article  PubMed  Google Scholar 

  74. Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R et al (2015) Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. J Intern Med 175(3):401–407

    Google Scholar 

  75. Moore AR, O’Keeffe ST (1999) Drug-induced cognitive impairment in the elderly. Drugs Aging 15(1):15–28

    Article  CAS  PubMed  Google Scholar 

  76. Martin NJ, Stones MJ, Young JE, Bedard M (2000) Development of delirium: a prospective cohort study in a community hospital. Int Psychogeriatr 12(1):117–127

    Article  CAS  PubMed  Google Scholar 

  77. Hein C, Forgues A, Piau A, Sommet A, Vellas B, Nourhashemi F (2014) Impact of polypharmacy on occurrence of delirium in elderly emergency patients. J Am Med Dir Assoc 15(11):850.e11–850.e15

    Article  Google Scholar 

  78. Oyarzun-Gonzalez XA, Taylor KC, Myers SR, Muldoon SB, Baumgartner RN (2015) Cognitive decline and polypharmacy in an elderly population. J Am Geriatr Soc 63(2):397–399

    Article  PubMed  PubMed Central  Google Scholar 

  79. Zhao YL, Kim H (2015) Older adult inpatient falls in acute care hospitals: intrinsic, extrinsic, and environmental factors. J Gerontol Nurs 41(7):29–43; quiz 44–5

    Article  CAS  PubMed  Google Scholar 

  80. Rubenstein LZ, Josephson KR (2002) The epidemiology of falls and syncope. Clin Geriatr Med 18(2):141–158

    Article  PubMed  Google Scholar 

  81. Souchet E, Lapeyre-Mestre M, Montastruc JL (2005) Drug related falls: a study in the French pharmacovigilance database. Pharmacoepidemiol Drug Saf 14(1):11–16

    Article  PubMed  Google Scholar 

  82. Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM et al (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169(21):1952–1960

    Article  PubMed  Google Scholar 

  83. Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH (2012) The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med 172(22):1739–1744

    Article  PubMed  Google Scholar 

  84. Wang R, Chen L, Fan L, Gao D, Liang Z, He J et al (2015) Incidence and effects of polypharmacy on clinical outcome among patients aged 80+: a five-year follow-up study. PLoS One 10(11):e0142123

    Article  PubMed  PubMed Central  Google Scholar 

  85. Fletcher PC, Berg K, Dalby DM, Hirdes JP (2009) Risk factors for falling among community-based seniors. J Patient Saf 5(2):61–66

    Article  PubMed  Google Scholar 

  86. Kojima T, Akishita M, Nakamura T, Nomura K, Ogawa S, Iijima K et al (2012) Polypharmacy as a risk for fall occurrence in geriatric outpatients. Geriatr Gerontol Int 12(3):425–430

    Article  PubMed  Google Scholar 

  87. Lai SW, Liao KF, Liao CC, Muo CH, Liu CS, Sung FC (2010) Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore) 89(5):295–299

    Article  Google Scholar 

  88. Lu WH, Wen YW, Chen LK, Hsiao FY (2015) Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study. CMAJ 187(4):E130–E137

    Article  PubMed  PubMed Central  Google Scholar 

  89. Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society (2011) Summary of the updated American geriatrics society/British geriatrics society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc 59(1):148–157

    Article  Google Scholar 

  90. Cooper JA, Cadogan CA, Patterson SM, Kerse N, Bradley MC, Ryan C et al (2015) Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open 5(12):e009235, 2015-009235

    Article  PubMed  PubMed Central  Google Scholar 

  91. Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA (2004) Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2(4):257–264

    Article  PubMed  Google Scholar 

  92. Taylor CT, Byrd DC, Krueger K (2003) Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm 60(11):1123–1129

    PubMed  Google Scholar 

  93. Trygstad TK, Christensen DB, Wegner SE, Sullivan R, Garmise JM (2009) Analysis of the North Carolina long-term care polypharmacy initiative: a multiple-cohort approach using propensity-score matching for both evaluation and targeting. Clin Ther 31(9):2018–2037

    Article  PubMed  Google Scholar 

  94. Spinewine A, Swine C, Dhillon S, Lambert P, Nachega JB, Wilmotte L et al (2007) Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc 55(5):658–665

    Article  PubMed  Google Scholar 

  95. Gallagher PF, O’Connor MN, O’Mahony D (2011) Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 89(6):845–854

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy and Faculty of Medicine, Dalhousie University, Halifax, NS, Canada

    Susan K. Bowles PharmD, MSc

  2. Department of Pharmacy and Centre for Health Care of the Elderly, Nova Scotia Health Authority – Central Zone, Halifax, NS, Canada

    Susan K. Bowles PharmD, MSc

Authors
  1. Susan K. Bowles PharmD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susan K. Bowles PharmD, MSc .

Editor information

Editors and Affiliations

  1. University of Ottawa and The Ottawa Hospital, Head, Division of Geriatric Medicine University of Ottawa and The Ottawa Hosp, Montréal, Québec, Canada

    Allen R. Huang

  2. Head, Faculty of Pharmacy Université de Montréal, Université de Montréal, Montréal, Québec, Canada

    Louise Mallet

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Bowles, S.K. (2016). Polypharmacy. In: Huang, A., Mallet, L. (eds) Medication-Related Falls in Older People. Adis, Cham. https://doi.org/10.1007/978-3-319-32304-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-32304-6_4

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-32302-2

  • Online ISBN: 978-3-319-32304-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation